Ritter, A M <br/><br/>
Prognostic significance of bromodeoxyuridine labeling in primary and recurrent glioblastoma multiforme.  [electronic resource] 

 -  Neurosurgery  Aug 1994 
 - 192-8; discussion 198 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0148-396X 
<br/><br/><label>Standard No.: </label>10.1227/00006123-199408000-00003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Brain--pathology<br/>Brain Neoplasms--mortality<br/>Bromodeoxyuridine<br/>Cell Division--physiology<br/>Chemotherapy, Adjuvant<br/>Combined Modality Therapy<br/>Female<br/>Follow-Up Studies<br/>Glioblastoma--mortality<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Mitotic Index<br/>Neoplasm Recurrence, Local--mortality<br/>Prognosis<br/>Radiotherapy, Adjuvant<br/>Reoperation<br/>Survival Rate